2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
28
Neoplasms
13
Colonic Neoplasms
12
Breast Neoplasms
12
Prostatic Neoplasms
9
Polycythemia Vera
9
Venous Thromboembolism
8
Multiple Myeloma
8
Recurrence
6
Carcinoma, Non-Small-Cell Lung
6
Rectal Neoplasms
5
Thrombocythemia, Essential
4
Ovarian Neoplasms
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Esophageal Neoplasms
4
Cardiovascular Diseases
4
Barrett Esophagus
4
Stomach Neoplasms
3
Precancerous Conditions
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Adenomatous Polyps
3
Adenoma
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Smoking Cessation
2
Interventions
Zoledronic Acid
4
Denosumab
4
Toremifene
2
Aromatase Inhibitors
2
radium Ra 223 dichloride
1
Vitamin D
1
Tobacco Products
1
Propofol
1
Neuroleptanalgesia
1
Midazolam
1
Letrozole
1
Hormone Replacement Therapy
1
Heart Disease Risk Factors
1
Exercise
1
Etomidate
1
Ethanol
1
Cholecalciferol
1
Cari-D-Tect
1
Aspirin
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fractures, Bone
×
Aspirin
×
Clear all
NCT01646437
2021-09-16
TIPS-3
Population Health Research Institute
Phase 3
Completed
7,793 enrolled